Coherus Oncology
(NASDAQ) CHRS
Coherus Oncology Financials at a Glance
Market Cap
$256.31M
Revenue (TTM)
$42.17M
Net Income (TTM)
$168.02M
EPS (TTM)
$-1.46
P/E Ratio
-1.17
Dividend
$0.00
Beta (Volatility)
1.64 (High)
Dividend
$0.00
Beta (Volatility)
1.64 (High)
Price
$1.76
Volume
84,327
Open
$1.71
Price
$1.76
Volume
84,327
Open
$1.71
Previous Close
$1.76
Daily Range
$1.71 - $1.85
52-Week Range
$0.71 - $2.62
Dividend
$0.00
Beta (Volatility)
1.64 (High)
Price
$1.76
Volume
84,327
Open
$1.71
Previous Close
$1.76
Daily Range
$1.71 - $1.85
52-Week Range
$0.71 - $2.62
CHRS News
CHRS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Coherus Oncology
Industry
Biotechnology
Sector
Health CareEmployees
147
CEO
Denny M. Lanfear, MBA
Website
www.coherus.comHeadquarters
Redwood City, CA 94065, US
CHRS Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
-4%
Net Income Margin
4%
Return on Equity
-861%
Return on Capital
-2%
Return on Assets
65%
Earnings Yield
-85.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$256.31M
Shares Outstanding
149.89M
Volume
84.33K
Short Interest
0.00%
Avg. Volume
2.28M
Financials (TTM)
Gross Profit
$28.36M
Operating Income
$181.13M
EBITDA
$170.20M
Operating Cash Flow
$138.51M
Capital Expenditure
$0.00
Free Cash Flow
$138.51M
Cash & ST Invst.
$172.13M
Total Debt
$40.34M
Coherus Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.75M
-76.5%
Gross Profit
$8.70M
-57.1%
Gross Margin
68.27%
N/A
Market Cap
$256.31M
N/A
Market Cap/Employee
$1.12M
N/A
Employees
228
N/A
Net Income
$37.64M
+25.7%
EBITDA
$43.20M
+2.5%
Quarterly Fundamentals
Net Cash
$131.79M
+191.6%
Accounts Receivable
$18.42M
-84.9%
Inventory
$3.17M
-95.5%
Long Term Debt
$38.51M
-85.6%
Short Term Debt
$1.83M
+8.1%
Return on Assets
65.04%
N/A
Return on Invested Capital
-1.56%
N/A
Free Cash Flow
$19.72M
-168.9%
Operating Cash Flow
$19.72M
-168.9%